DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 2.18% to $762.81 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.38% to 51,850.55 and the S&P 500 Index falling 0.06% to 7,807.24.
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 11.23% below its 52-week high of $859.34, which the company reached on September 3rd.
The stock outperformed some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 0.65% to $417.57, Moderna Inc. (MRNA) fell 5.00% to $213.74, and Gilead Sciences Inc. (GILD) fell 0.49% to $150.43.
Trading volume (613,470) remained 109,322 below its 50-day average volume of 722,792.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.